Invention Grant
![Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitors](/docs/US/2020-09-01/US10758542B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitors
-
Application No.: US16377514Application Date: 2019-04-08
-
Publication No.: US10758542B2Publication Date: 2020-09-01
- Inventor: Shelley Allen , Steven W. Andrews , Kevin Ronald Condroski , Julia Haas , Lily Huang , Yutong Jiang , Timothy Kercher , Jeongbeob Seo
- Applicant: Array BioPharma Inc.
- Applicant Address: US CO Boulder
- Assignee: Array BioPharma Inc.
- Current Assignee: Array BioPharma Inc.
- Current Assignee Address: US CO Boulder
- Agency: Meunier Carlin & Curfman LLC
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D519/00 ; C07D487/04 ; C07D453/02 ; C07D471/22 ; C07D498/22 ; A61K31/5377
![Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitors](/abs-image/US/2020/09/01/US10758542B2/abs.jpg.150x150.jpg)
Abstract:
Compounds of Formula I: and salts thereof in which R1, R2, R3, R4, X, Y and n have the meanings given in the specification, are inhibitors of Trk kinases and are useful in the treatment of diseases which can be treated with a Trk kinase inhibitor such as pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases.
Public/Granted literature
- US20190365763A1 SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS Public/Granted day:2019-12-05
Information query
IPC分类:
